Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis-Reference-Cited by-同舟云学术

Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis

Published:2009 Issue:3 Volume:134 Page:149-157
ISSN:0015-5691
Container-title:Folia Pharmacologica Japonica
language:ja
Short-container-title:Folia Pharmacol. Jpn.

Author:

Tanaka Makoto,Mori Hiroshi,Shimizu Kiyoshi,Matsuoka Toshiyuki,Yamamotoya Hajime,Minamide Toshiomi,Mori Masamichi,Nozaki Kazutoshi,Usui Takashi,Shimokawa Kenichiro,Suzuki Hiromi,Aoyama Koji,Kimoto Aishi,Sasamata Masao,Miyata Keiji

Publisher

Japanese Pharmacological Society

Subject

Pharmacology

Reference24 articles.

1. Osteoporosis Prevention, Diagnosis, and Therapy

2. 2) 山本逸雄. Osteoporos Jpn. 1999;7:10-11.

3. Bone Resorption by Osteoclasts

4. 4) Fleisch H. Bisphosphonates in bone disease. From the laboratory to the patient. 4th ed. Academic Press; 2000. p. 27-66.

5. 5) 田中郁子, 他. 日本臨床. 2004;62:492-495.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation on the structural characteristics and polymorphic transformation mechanism of polymorphic hydrates: a case of minodronic acid monohydrate;Phase Transitions;2023-12-09

2. Pharmacokinetics and Tolerability of Minodronic Acid Tablets in Healthy Chinese Subjects and Food and Age Effects on the Pharmacokinetics;Clinical Therapeutics;2015-04

3. Effects of minodronate on cortical bone response to mechanical loading in rats;Bone;2013-03

4. A review of minodronic acid hydrate for the treatment of osteoporosis;Clinical Interventions in Aging;2013-02